Management of Medication-Related Adverse Effects
- 1 April 2014
- book chapter
- Published by Springer Nature
- p. 225-262
Abstract
No abstract availableKeywords
This publication has 232 references indexed in Scilit:
- Strategies for the Treatment of Antipsychotic-Induced Sexual Dysfunction and/or Hyperprolactinemia Among Patients of the Schizophrenia Spectrum: A ReviewJournal of Sex & Marital Therapy, 2012
- When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literatureSchizophrenia Research, 2012
- Factors affecting the degree of QT prolongation with drug challenge in a large cohort of normal volunteersHeart Rhythm, 2011
- Second-Generation Antipsychotic Drugs and Extrapyramidal Side Effects: A Systematic Review and Meta-analysis of Head-to-Head ComparisonsSchizophrenia Bulletin, 2010
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac DeathNew England Journal of Medicine, 2009
- Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1Schizophrenia Research, 2008
- A Case Series: Evaluation of the Metabolic Safety of AripiprazoleSchizophrenia Bulletin, 2006
- Venous Thromboembolism Among Elderly Patients Treated With Atypical and Conventional Antipsychotic AgentsArchives of internal medicine (1960), 2005
- Drug-Induced Prolongation of the QT IntervalNew England Journal of Medicine, 2004
- Role of Amantadine in the Management of Neuroleptic-Induced Extrapyramidal SyndromesClinical Neuropharmacology, 1983